Figure 5.
Assessment of the biological hemostatic properties in VWF2N mice whole blood. Blood samples were collected from the vena cava (terminal experiment) using 3.8% sodium citrate as an anticoagulant (vol/vol 1:10) and analyzed by nonactivated ROTEM analysis and nWB-TGA. (A) ROTEM analysis of whole blood. ROTEM standard cups were preloaded with 21 µL of 0.2M CaCl2, and then 300 µL of whole blood was added. Clot formation was recorded using the NATEM measurement until maximum clot firmness reached its peak. (B) nWB-TGA analysis of whole blood. Fifteen microliters of whole blood was recalcified in the presence of a rhodamine-based, thrombin-cleavable, fluorescent substrate and added in duplicate to filter paper placed within the wells of a black 96-well plate. Change in fluorescence was measured over time and converted to thrombin generation. Conversions were calculated from a curve generated during a calibration experiment using a thrombin standard. C57BL/6J and VWF−/− mice served as controls. *P < .05; **P < .01; ***P < .001. These data demonstrate that functional hemostatic properties in VWF2N/2N whole blood are defective.